

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | DDR1-IN-1 exhibits potent and selective inhibition of the DDR1 receptor tyrosine kinase, with an IC50 of 105 nM. It is approximately four times less potent for DDR2, with an IC50 of 413 nM[1]. |
| 体外研究 | In U2OS cells, DDR1-IN-1 effectively hinders collagen-induced DDR1 pY513 autophosphorylation, with an EC50 of 86.76 nM, demonstrating excellent selectivity over a panel of >380 kinases. Additionally, DDR1-IN-1 suppresses DDR2-mediated MT1-MMP activation in human rheumatoid synovial fibroblasts (RASF) following collagen stimulation, with an IC50 of less than 2.5 μM. Moreover, it enhances the antiproliferation efficacy of the PI3K/mTOR inhibitor GSK2126458 in SNU-1040 colorectal cancer culture[1]. |
| Concentration | Treated Time | Description | References | |
| SkBr3 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| SaoS2 cells | 8.14 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| H1975 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| A549 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| T47D cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| HCT-116 cells | 8.7 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| U2OS cells | 86 nM | Inhibition of DDR1 autophosphorylation | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| MPNST cell line STS26T | 1-10 µM | 24 h | Detect LC3B-II accumulation, DDR1-IN-1 dose-dependently induced autophagy | Cell Death Discov. 2025 Mar 1;11(1):83. |
| MPNST cell line S462 | 12.4 µM (IC50) | 48 h | Assess cell viability, DDR1-IN-1 drastically reduced cell viability within a narrow concentration range | Cell Death Discov. 2025 Mar 1;11(1):83. |
| SNU-449 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| EJ cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| SNU-1040 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| SW480 cells | >10 μM | Anti-proliferation effect | ACS Chem Biol. 2013 Oct 18;8(10):2145-50. | |
| Liver sinusoidal endothelial cells (LSECs) | 70 nM | 3 h | DDR1-IN-1 did not significantly modify MMPs secretion in LSECs. | Sci Rep. 2020 Oct 27;10(1):18398. |
| Kupffer cells (KCs) | 70 nM | 3 h | DDR1-IN-1 reduced the expression of active MMP9 in KCs but did not significantly affect total MMPs secretion. | Sci Rep. 2020 Oct 27;10(1):18398. |
| Hepatic stellate cells (HSCs) | 70 nM | 3 h | DDR1-IN-1 decreased MMP2 and MMP9 secretion in HSCs and reduced the promotion of LSECs and C26 cell migration and proliferation by HSC-derived factors. | Sci Rep. 2020 Oct 27;10(1):18398. |
| U2OS cells | 105 nM | 2 h | Evaluate the inhibitory effect of DDR1-IN-1 on collagen-induced DDR1 autophosphorylation | J Mol Biol. 2014 Jun 26;426(13):2457-70. |
| LN-229 | 4.99 µM | 24 h | Investigation of the effect of DDR1-IN-1 on the radiosensitivity of glioblastoma cells, showing that DDR1-IN-1 combined with cilengitide significantly enhanced radiosensitivity. | Am J Cancer Res. 2023 Oct 15;13(10):4597-4612. |
| U-251MG | 4.99 µM | 24 h | Investigation of the effect of DDR1-IN-1 on the radiosensitivity of glioblastoma cells, showing that DDR1-IN-1 combined with cilengitide significantly enhanced radiosensitivity. | Am J Cancer Res. 2023 Oct 15;13(10):4597-4612. |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c mice | Colon carcinoma liver metastasis model | Tail vein injection | 1.5 mg/kg | Three consecutive days, once daily | DDR1 silencing reduced the number and size of metastatic foci in the liver and decreased collagen and MMPs activity in the tumor microenvironment. | Sci Rep. 2020 Oct 27;10(1):18398. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.81mL 0.36mL 0.18mL |
9.05mL 1.81mL 0.90mL |
18.10mL 3.62mL 1.81mL |
|
| CAS号 | 1449685-96-4 |
| 分子式 | C30H31F3N4O3 |
| 分子量 | 552.59 |
| SMILES Code | O=C(NC1=CC=C(C)C(OC2=CC3=C(NC(C3)=O)C=C2)=C1)C4=CC=C(CN5CCN(CC)CC5)C(C(F)(F)F)=C4 |
| MDL No. | MFCD28144507 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(190.02 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1